Abiopharma

🔍 MORTIMER IAN (Executive)

Company: Xenon Pharmaceuticals Inc. (XENE)

Report Date: 2026-03-09

Detailed Transactions and Holdings:

• Acquired 75,000 shares of Common Shares at $8.4 per share (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | shares_owned_after: 81,000.00 | transaction_form_type: 4
• Sold 21,791 shares of Common Shares at $58.81 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 59,209.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 31,694 shares of Common Shares at $59.88 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 27,515.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 21,515 shares of Common Shares at $60.49 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Acquired 25,000 shares of Common Shares at $3.1 per share (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | shares_owned_after: 31,000.00 | transaction_form_type: 4
• Sold 12,479 shares of Common Shares at $59.5 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 18,521.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 10,072 shares of Common Shares at $60.47 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 8,449.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 2,449 shares of Common Shares at $61.26 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Acquired 105,000 shares of Common Shares at $4.75 per share (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | shares_owned_after: 111,000.00 | transaction_form_type: 4
• Sold 43,348 shares of Common Shares at $59.26 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 72,652.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 61,652 shares of Common Shares at $60.08 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Acquired 65,000 shares of Common Shares at $9.44 per share (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | shares_owned_after: 71,000.00 | transaction_form_type: 4
• Sold 65,000 shares of Common Shares at $62.06 per share (Direct)
  Date: 2026-03-09 | Code: S | equity_swap_involved: false | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Acquired 20,000 shares of Common Shares (Direct)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | shares_owned_after: 26,000.00 | transaction_form_type: 4 | Footnotes: F11, F11
• Sold 11,269 shares of Common Shares at $60.108 per share (Direct)
  Date: 2026-03-10 | Code: S | equity_swap_involved: false | shares_owned_after: 14,731.00 | transaction_form_type: 4 | Footnotes: F12
• Holds 0 shares of Common Shares (Direct)
  Date: 2026-03-09 | Code: H | nature_of_ownership: By Spouse | shares_owned_after: 14,300.00
• Sold 75,000 shares of Stock Option at $8.4 per share (Derivative)
  Date: 2026-03-09 | Code: M | Expires: 2027-03-12 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F13
• Sold 25,000 shares of Stock Option at $3.1 per share (Derivative)
  Date: 2026-03-09 | Code: M | Expires: 2027-10-22 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F13
• Sold 105,000 shares of Stock Option at $4.75 per share (Derivative)
  Date: 2026-03-09 | Code: M | Expires: 2028-03-11 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F13
• Sold 65,000 shares of Stock Option at $9.44 per share (Derivative)
  Date: 2026-03-09 | Code: M | Expires: 2029-09-15 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F13
• Acquired 20,000 shares of Performance Share Units (Derivative)
  Date: 2026-03-09 | Code: A | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F11, F11, F11, F11
• Sold 20,000 shares of Performance Share Units (Derivative)
  Date: 2026-03-09 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F11, F11, F11

Footnotes:

• F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024.
• F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.16 to $59.1425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F3: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.16 to $60.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F4: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.16 to $61.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F5: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.03 to $60.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F6: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.05 to $61.035, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F7: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $61.055 to $61.555, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F8: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.745 to $59.735, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F9: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F10: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F11: Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination.
• F12: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024.
• F13: The shares subject to this option are fully vested and exercisable.